Thymus Extract - Synribo (Omacetaxine Mepesuccinate) Interaction

Interaction Details

Omacetaxine Mepesuccinate is classified as belonging to the following category: Immunosuppressants

Theoretically, patients taking immunosuppressants may be at an increased risk of infection from contaminated thymus extract.
Thymus extract is derived from raw bovine thymus glands and is at risk for contamination. Tell patients to avoid thymus extract products unless these products are certified as pathogen-free.

Interaction Rating

Likelihood of Occurrence

Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists

References

• Lewis CJ. Letter to reiterate certain public health and safety concerns to firms manufacturing or importing dietary supplements that contain specific bovine tissues. FDA. Available at: www.cfsan.fda.gov/~dms/dspltr05.html.

Omacetaxine Mepesuccinate Overview

• Omacetaxine injection is used to treat adults with chronic myelogenous leukemia (CML; a type of cancer of the white blood cells) who have already been treated with at least two other medications for CML and can no longer benefit from these medications or cannot take these medications due to side effects. Omacetaxine injection is in a class of medications called protein synthesis inhibitors. It works by slowing the growth of cancer cells.

Thymus Extract - More Interactions

Thymus Extract interacts with 112 drugs

Interaction Rating Key

These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.